1 – 10 of 79
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- The role of interleukin-17A in the pathogenesis of kidney diseases
- Alterations of CXCL12 in Serum of Patients with Vitiligo
- The intriguing role of soluble urokinase receptor in inflammatory diseases
- S100B is a potential disease activity marker in non-segmental vitiligo
- A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
- Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo
- Secukinumab: IL-17A inhibition to treat psoriatic arthritis
- Meeting report: Vitiligo Global Issues Consensus Conference Workshop 'Outcome measurement instruments' and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd
- Segmental Vitiligo
- Development and validation of a patient-reported outcome measure in vitiligo : the Self Assessment Vitiligo Extent Score (SA-VES)